{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:42:21Z","timestamp":1768527741254,"version":"3.49.0"},"posted":{"date-parts":[[2025,11,26]]},"group-title":"Microbiology","reference-count":71,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,11,26]]},"abstract":"<jats:label>1.<\/jats:label>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  O\u2019nyong-nyong virus (ONNV) is a mosquito-borne alphavirus first isolated in Uganda in 1959. Since its discovery, ONNV has caused several outbreaks in Africa, manifesting clinically as fever, rash, and joint\/muscle pain lasting months. Currently, we have a limited understanding of ONNV infection and disease in relevant animal models, which restricts the evaluation of vaccines and therapeutics. In 1967, Binn et al. reported that infection of rhesus macaques (RMs) with ONNV failed to induce viremia in two animals. This may be attributed to the potential attenuation of the virus through extensive passaging. To mitigate this issue, we constructed an infectious clone from the sequence of ONNV-UVRI0804 (ONNV\n                  <jats:sub>0804<\/jats:sub>\n                  ), a 2017 clinical isolate from a febrile patient in Uganda. This strain demonstrated high pathogenicity in immunocompetent mice, resulting in an earlier and more severe onset of disease and significantly higher viremia compared to a highly passaged control strain ONNV\n                  <jats:sub>UgMP30<\/jats:sub>\n                  . In the current study, three male and three female rhesus macaques were subcutaneously inoculated with ONNV\n                  <jats:sub>0804<\/jats:sub>\n                  . All animals became viremic at 2 days post inoculation (dpi). Both classical and nonclassical monocytes were activated (CD169+), peaking at 3 dpi, which corresponded with the peak of viremia. Additionally, CD4+ and CD8+ effector memory T cells and memory B cells began proliferating in peripheral blood by day 7, peaking at day 10, which also corresponded to the timing of neutralizing antibody development, indicating a robust adaptive immune response to ONNV\n                  <jats:sub>0804<\/jats:sub>\n                  . Finally, key clinical disease manifestations were recapitulated, including lymphadenopathy and histological features of early-stage arthritis. Taken together, rhesus macaque infection with ONNV\n                  <jats:sub>0804<\/jats:sub>\n                  clinical isolate is a promising model for investigating immune responses to alphaviruses and evaluating vaccines to protect against future epidemics.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:label>2.<\/jats:label>\n                  <jats:title>Author summary<\/jats:title>\n                  <jats:p>\n                    O\u2019nyong-nyong virus (ONNV) is a mosquito-transmitted alphavirus that causes fever, rash, and prolonged joint and muscle pain, similar to chikungunya virus and other arthritogenic alphaviruses. Despite its capacity to cause outbreaks in Africa, ONNV remains understudied, and there are currently no approved vaccines or therapeutics to prevent or treat infection and disease. A major barrier to advancing ONNV research has been the lack of suitable animal models to study the virus and investigate host immune responses. We engineered an ONNV infectious clone of a recent clinical isolate sequenced from a patient in Uganda (ONNV\n                    <jats:sub>0804<\/jats:sub>\n                    ) that causes robust infection and disease in immunocompetent mice. In the current study, we provide data demonstrating that this contemporary ONNV strain infects rhesus macaques. Notably, rhesus macaques developed detectable viremia, rash, lymphadenopathy, joint and muscle inflammation, and strong innate and adaptive immune responses following subcutaneous ONNV\n                    <jats:sub>0804<\/jats:sub>\n                    infection. These findings suggest that ONNV\n                    <jats:sub>0804<\/jats:sub>\n                    infection in macaques is a promising model for studying ONNV pathogenesis and immunity. This model will be instrumental for evaluating future vaccine and therapeutic candidates aimed at preventing ONNV infection and related viral disease.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.11.20.689439","type":"posted-content","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:05:13Z","timestamp":1764151513000},"source":"Crossref","is-referenced-by-count":0,"title":["Infection Of Rhesus Macaques With O\u2019nyong-nyong Virus UVIR-O804 Recapitulates Key Aspects of Human Clinical Disease"],"prefix":"10.64898","author":[{"given":"Hannah K.","family":"Jaeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Denton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi F.","family":"Andoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig N.","family":"Kreklywich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia J.","family":"Pung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary J.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"McMonigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brayden","family":"Graves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalene M.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron M.","family":"Barber-Axthelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Zilverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne S.","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Axthelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caralyn S.","family":"Labriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Heise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-2492","authenticated-orcid":false,"given":"Daniel N.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025112617150785000_2025.11.20.689439v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(60)90025-0"},{"key":"2025112617150785000_2025.11.20.689439v1.2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9437"},{"key":"2025112617150785000_2025.11.20.689439v1.3","doi-asserted-by":"publisher","DOI":"10.1086\/315073"},{"key":"2025112617150785000_2025.11.20.689439v1.4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1208.060199"},{"issue":"1","key":"2025112617150785000_2025.11.20.689439v1.5","doi-asserted-by":"crossref","first-page":"2355201","DOI":"10.1080\/21505594.2024.2355201","article-title":"Pathogenicity and virulence of O\u2019nyong-nyong virus: A less studied Togaviridae with pandemic potential","volume":"15","year":"2024","journal-title":"Virulence"},{"key":"2025112617150785000_2025.11.20.689439v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(81)90325-4"},{"key":"2025112617150785000_2025.11.20.689439v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(62)90073-1"},{"key":"2025112617150785000_2025.11.20.689439v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(65)90012-X"},{"key":"2025112617150785000_2025.11.20.689439v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.011"},{"key":"2025112617150785000_2025.11.20.689439v1.10","unstructured":"Organization WH. Vector-borne diseases Geneva: World Health Organization; 2024 [updated 26 September 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/vector-borne-diseases."},{"issue":"9","key":"2025112617150785000_2025.11.20.689439v1.11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/tropicalmed7090204","article-title":"Recent Technological Advances and Strategies for Arbovirus Vector Control","volume":"7","year":"2022","journal-title":"Tropical Medicine and Infectious Disease"},{"key":"2025112617150785000_2025.11.20.689439v1.12","doi-asserted-by":"publisher","DOI":"10.1086\/313462"},{"key":"2025112617150785000_2025.11.20.689439v1.13","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.1.0730032"},{"key":"2025112617150785000_2025.11.20.689439v1.14","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2017.1355431"},{"issue":"9","key":"2025112617150785000_2025.11.20.689439v1.15","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s10067-020-05011-9","article-title":"Persistent chikungunya arthritis in Roraima, Brazil","volume":"39","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025112617150785000_2025.11.20.689439v1.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190162"},{"issue":"8","key":"2025112617150785000_2025.11.20.689439v1.17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/tmi.13906","article-title":"Incidence and factors associated with chronic chikungunya arthritis following chikungunya virus infection","volume":"28","year":"2023","journal-title":"Trop Med Int Health"},{"key":"2025112617150785000_2025.11.20.689439v1.18","first-page":"29853","article-title":"Global emergence of Alphaviruses that cause arthritis in humans","volume":"5","year":"2015","journal-title":"Infect Ecol Epidemiol"},{"key":"2025112617150785000_2025.11.20.689439v1.19","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-00987-y"},{"key":"2025112617150785000_2025.11.20.689439v1.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007880"},{"key":"2025112617150785000_2025.11.20.689439v1.21","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1981.30.682"},{"key":"2025112617150785000_2025.11.20.689439v1.22","first-page":"973516","article-title":"Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis","volume":"2013","year":"2013","journal-title":"Biomed Res Int"},{"key":"2025112617150785000_2025.11.20.689439v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.03.009"},{"issue":"3","key":"2025112617150785000_2025.11.20.689439v1.24","doi-asserted-by":"crossref","first-page":"e0012938","DOI":"10.1371\/journal.pntd.0012938","article-title":"Development of a virulent O\u2019nyong\u2019nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine","volume":"19","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"2025112617150785000_2025.11.20.689439v1.25","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.12-0674"},{"key":"2025112617150785000_2025.11.20.689439v1.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011742"},{"key":"2025112617150785000_2025.11.20.689439v1.27","doi-asserted-by":"crossref","unstructured":"Li A , Coffey LL , Mohr EL , Raper J , Chahroudi A , Ausderau KK , et al. Role of non-human primate models in accelerating research and developing countermeasures against Zika virus infection. Lancet Microbe. 2025:101030.","DOI":"10.1016\/j.lanmic.2024.101030"},{"key":"2025112617150785000_2025.11.20.689439v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0005-7"},{"key":"2025112617150785000_2025.11.20.689439v1.29","doi-asserted-by":"crossref","unstructured":"Haese NN , Roberts VHJ , Chen A , Streblow DN , Morgan TK , Hirsch AJ . Nonhuman Primate Models of Zika Virus Infection and Disease during Pregnancy. Viruses. 2021;13(10).","DOI":"10.3390\/v13102088"},{"issue":"5","key":"2025112617150785000_2025.11.20.689439v1.30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ame2.12471","article-title":"Applications and advancements in animal models for antiviral research on mosquito-borne arboviruses","volume":"7","year":"2024","journal-title":"Animal Model Exp Med"},{"key":"2025112617150785000_2025.11.20.689439v1.31","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1967.16.782"},{"key":"2025112617150785000_2025.11.20.689439v1.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002719"},{"key":"2025112617150785000_2025.11.20.689439v1.33","doi-asserted-by":"crossref","unstructured":"Zimmerman O , Holmes AC , Kafai NM , Adams LJ , Diamond MS . Entry receptors - the gateway to alphavirus infection. J Clin Invest. 2023;133(2).","DOI":"10.1172\/JCI165307"},{"issue":"1","key":"2025112617150785000_2025.11.20.689439v1.34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12985-017-0804-7","article-title":"Chikungunya virus infection in Cynomolgus macaques following Intradermal and aerosol exposure","volume":"14","year":"2017","journal-title":"Virol J"},{"key":"2025112617150785000_2025.11.20.689439v1.35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40104"},{"key":"2025112617150785000_2025.11.20.689439v1.36","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.10-0290"},{"key":"2025112617150785000_2025.11.20.689439v1.37","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400044442"},{"key":"2025112617150785000_2025.11.20.689439v1.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002343"},{"key":"2025112617150785000_2025.11.20.689439v1.39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01032-14"},{"key":"2025112617150785000_2025.11.20.689439v1.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005637"},{"key":"2025112617150785000_2025.11.20.689439v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2105"},{"issue":"12","key":"2025112617150785000_2025.11.20.689439v1.42","doi-asserted-by":"crossref","first-page":"e0069222","DOI":"10.1128\/mra.00692-22","article-title":"Complete Genome Sequence of O\u2019nyong Nyong Virus Isolated from a Febrile Patient in 2017 in Uganda","volume":"11","year":"2022","journal-title":"Microbiol Resour Announc"},{"key":"2025112617150785000_2025.11.20.689439v1.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006219"},{"issue":"4","key":"2025112617150785000_2025.11.20.689439v1.44","first-page":"909","article-title":"Fever Incidence Is Much Lower in the Morning than the Evening: Boston and US National Triage Data","volume":"21","year":"2020","journal-title":"West J Emerg Med"},{"issue":"3 Suppl","key":"2025112617150785000_2025.11.20.689439v1.45","first-page":"1s","article-title":"International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Non-proliferative and Proliferative Lesions of the Non-human Primate (M. fascicularis)","volume":"34","year":"2021","journal-title":"J Toxicol Pathol"},{"key":"2025112617150785000_2025.11.20.689439v1.46","unstructured":"CDC. CDC Yellow Book 2026: Health Information for International Travel: Chapter Chikungunya: Oxford University Press; 2025."},{"issue":"6","key":"2025112617150785000_2025.11.20.689439v1.47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v17060762","article-title":"Comparative Analysis of Two Zika Virus Isolates in a Rhesus Macaque Pregnancy Model","volume":"17","year":"2025","journal-title":"Viruses"},{"key":"2025112617150785000_2025.11.20.689439v1.48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02666-13"},{"key":"2025112617150785000_2025.11.20.689439v1.49","doi-asserted-by":"crossref","unstructured":"Teo TH , Chan YH , Lee WW , Lum FM , Amrun SN , Her Z , et al. Fingolimod treatment abrogates chikungunya virus-induced arthralgia. Sci Transl Med. 2017;9(375).","DOI":"10.1126\/scitranslmed.aal1333"},{"key":"2025112617150785000_2025.11.20.689439v1.50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02563"},{"key":"2025112617150785000_2025.11.20.689439v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.11.018"},{"issue":"1","key":"2025112617150785000_2025.11.20.689439v1.52","doi-asserted-by":"crossref","first-page":"19577","DOI":"10.1038\/s41598-022-24011-0","article-title":"Lung CCR6\u2212CXCR3\u2212 type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases","volume":"12","year":"2022","journal-title":"Scientific Reports"},{"key":"2025112617150785000_2025.11.20.689439v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62426-X"},{"key":"2025112617150785000_2025.11.20.689439v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04017-w"},{"key":"2025112617150785000_2025.11.20.689439v1.55","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.02.026"},{"key":"2025112617150785000_2025.11.20.689439v1.56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00928-3"},{"key":"2025112617150785000_2025.11.20.689439v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.023"},{"issue":"1","key":"2025112617150785000_2025.11.20.689439v1.58","doi-asserted-by":"crossref","first-page":"2355201","DOI":"10.1080\/21505594.2024.2355201","article-title":"Pathogenicity and virulence of O\u2019nyong-nyong virus: A less studied Togaviridae with pandemic potential","volume":"15","year":"2024","journal-title":"Virulence"},{"key":"2025112617150785000_2025.11.20.689439v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02499-9"},{"key":"2025112617150785000_2025.11.20.689439v1.60","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E"},{"key":"2025112617150785000_2025.11.20.689439v1.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.03.003"},{"key":"2025112617150785000_2025.11.20.689439v1.62","doi-asserted-by":"crossref","unstructured":"Torres-Ruesta A , Teo TH , Chan YH , Amrun SN , Yeo NK , Lee CY , et al. Malaria abrogates O\u2019nyong-nyong virus pathologies by restricting virus infection in nonimmune cells. Life Sci Alliance. 2022;5(4).","DOI":"10.26508\/lsa.202101272"},{"key":"2025112617150785000_2025.11.20.689439v1.63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00894"},{"key":"2025112617150785000_2025.11.20.689439v1.64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300304"},{"key":"2025112617150785000_2025.11.20.689439v1.65","doi-asserted-by":"crossref","unstructured":"Jung W , Abdelnour A , Kaplonek P , Herrero R , Shih-Lu Lee J , Barbati DR , et al. SARS-CoV-2 infection prior to vaccination amplifies Fc-mediated humoral profiles in an age-dependent manner. Cell Reports. 2024;43(9).","DOI":"10.1016\/j.celrep.2024.114684"},{"key":"2025112617150785000_2025.11.20.689439v1.66","doi-asserted-by":"crossref","unstructured":"Carissimo G , Teo TH , Chan YH , Lee CY , Lee B , Torres-Ruesta A , et al. Viperin controls chikungunya virus-specific pathogenic T cell IFN\u03b3 Th1 stimulation in mice. Life Sci Alliance. 2019;2(1).","DOI":"10.26508\/lsa.201900298"},{"key":"2025112617150785000_2025.11.20.689439v1.67","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00909-15"},{"key":"2025112617150785000_2025.11.20.689439v1.68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410"},{"key":"2025112617150785000_2025.11.20.689439v1.69","doi-asserted-by":"crossref","unstructured":"Broeckel R , Sarkar S , May NA , Totonchy J , Kreklywich CN , Smith P , et al. Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs. Antimicrob Agents Chemother. 2019;63(4).","DOI":"10.1128\/AAC.02325-18"},{"key":"2025112617150785000_2025.11.20.689439v1.70","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03116-13"},{"issue":"2","key":"2025112617150785000_2025.11.20.689439v1.71","doi-asserted-by":"crossref","first-page":"e13514","DOI":"10.1111\/tid.13514","article-title":"Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection","volume":"23","year":"2021","journal-title":"Transpl Infect Dis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.11.20.689439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:05:02Z","timestamp":1768471502000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.11.20.689439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1101\/2025.11.20.689439","relation":{},"subject":[],"published":{"date-parts":[[2025,11,26]]},"subtype":"preprint"}}